Table of Contents Author Guidelines Submit a Manuscript
Research Article
Mediators of Inflammation
Volume 2016, Article ID 3151986, 2 pages
http://dx.doi.org/10.1155/2016/3151986
Corrigendum

Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”

1Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
2Department of Gerontology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
3Department of Emergency, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China

Received 8 June 2016; Accepted 15 August 2016

Copyright © 2016 Xiao-Wen Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


In the article titled “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice” [1], in Figure 3(c)(A), the value of ordinate should be narrowed down to 0.01 times that of the data presented. And in Figure 6(b), the abscissa p-65/p65 should be changed to p-p65/p65. The two corrected figures are presented here.

Figure 3: Irb alleviated diabetes-induced podocyte injury and the thickening of the GBM. (a) Representative fields of podocyte foot processes under TEM (scale bars: 2 μm; red arrow indicates podocyte foot process effacement). (b) Representative fields of nephrin, as labeled by immunohistochemical staining (scale bars: 50 μm). (c) Quantification of the GBM thickness (A) and immunohistochemical staining (B). The bars in panel (c) show the mean expression in arbitrary units (error bars, SD). compared with db/m; compared with db/db, -test.